Type of security: Stock
Sector: Consumer Durables
Industry: Specialty Chemicals
The data is delayed by 15 minutes.
Description: Cyanotech Corporation is engaged in the cultivation, production, and sale of natural products derived from microalgae worldwide. The company?s products include Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids; and Hawaiian BioAstin natural astaxanthin, a dietary antioxidant, which is used as a human nutraceutical and functional food ingredient to support and maintain the body?s natural inflammatory response, enhance skin, and support eye and joint health. Cyanotech Corporation sells its products in bulk quantities to manufacturers, formulators, and distributors in the health foods and nutritional supplements markets; and as packaged consumer products to distributors, retailers, and direct consumers. The company sells its products online and through resellers. Cyanotech Corporation was founded in 1983 and is headquartered in Kailua-Kona, Hawaii.
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||18.8%||Sales Growth - Q/Q||-0.01%||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||-0.08%||ROE||-0.11%||ROI|
|Current Ratio||2.73||Quick Ratio||1.42||Long Term Debt/Equity||0.68||Debt Ratio||0.2|
|Gross Margin||42.79%||Operating Margin||0.95%||Net Profit Margin||-0.07%||Dividend Payout Ratio|
|Cash From Financing Activities||90 K||Cash From Investing Activities||-3.42 M||Cash From Operating Activities||1.24 M||Gross Profit||2.87 M|
|Net Profit||-100 K||Operating Profit||140 K||Total Assets||30.91 M||Total Current Assets||11.79 M|
|Total Current Liabilities||4.32 M||Total Debt||5.34 M||Total Liabilities||9.43 M||Total Revenue||8.84 M|
|High 52 week||4.05||Low 52 week||2.28||Last close||2.37||Last change||2.6%|
|RSI||53.66||Average true range||0.09||Beta||0.38||Volume||11.19 K|
|Simple moving average 20 days||0%||Simple moving average 50 days||-3.07%||Simple moving average 200 days||-20.65%|
|Performance Week||2.16%||Performance Month||-3.66%||Performance Quart||-4.82%||Performance Half||-24.63%|
|Performance Year||-29.67%||Performance Year-to-date||-21.52%||Volatility daily||3.29%||Volatility weekly||7.36%|
|Volatility monthly||15.08%||Volatility yearly||52.24%||Relative Volume||200.28%||Average Volume||2.33 K|
|New High||New Low|
2020-04-11 14:00:00 | Cyanotech® Donates Protein Powder and Medical Supplies to Local Hospitals
2019-10-11 07:10:51 | Did Changing Sentiment Drive Cyanotech's NASDAQ:CYAN Share Price Down By 49%?
2019-08-27 08:30:50 | Is Cyanotech NASDAQ:CYAN Using Too Much Debt?
2019-08-13 08:00:00 | Cyanotech Reports Financial Results for the First Quarter of Fiscal 2020
2019-07-13 10:50:16 | Is Cyanotech Corporation's NASDAQ:CYAN Balance Sheet Strong Enough To Weather A Storm?
2019-07-01 14:29:40 | Cyanotech Trades Lower After Reporting Q4 Losses
2019-07-01 08:00:00 | Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2019
2019-04-03 19:49:00 | Cyanotech® Corporation Earns Blue Zones® Certification
2019-01-13 10:53:52 | Stocks That Fell to 3-Year Lows in the Week of Jan. 11
2019-01-09 08:00:00 | Cyanotech Names Brian Orlopp as VP Finance & Chief Financial Officer
2018-08-13 08:00:00 | Cyanotech Reports Financial Results for the First Quarter of Fiscal Year 2019
2018-06-18 17:59:11 | Cyanotech reports $1M net income for fiscal year 2018
2018-06-15 08:00:00 | Cyanotech Reports Financial Results for the Fourth Quarter and Fiscal Year 2018
2018-02-06 08:30:00 | Cyanotech Reports Financial Results for the Third Quarter of Fiscal Year 2018
2018-02-05 08:49:14 | Are Cyanotech Corporation’s NASDAQ:CYAN Interest Costs Too High?
2018-01-23 14:43:21 | Should You Be Tempted To Sell Cyanotech Corporation NASDAQ:CYAN Because Of Its PE Ratio?
2017-12-25 09:38:08 | Cyanotech Corp. :CYAN-US: Earnings Analysis: Q2, 2018 By the Numbers : December 25, 2017
2017-11-21 13:19:08 | With An ROE Of 2.01%, Has Cyanotech Corporation’s CYAN Management Done A Good Job?
2017-11-06 08:00:00 | Cyanotech Reports Financial Results for the Second Quarter of Fiscal Year 2018
2017-08-10 08:00:00 | Cyanotech Reports Financial Results for First Quarter of Fiscal Year 2018
2017-08-07 08:00:00 | Cyanotech to Hold Investor Broadcast on Friday, August 11, 2017
2017-07-17 18:00:00 | Cyanotech Names Mawae Morton President
2017-06-26 12:53:15 | Cyanotech Corp. :CYAN-US: Earnings Analysis: Q4, 2017 By the Numbers : June 26, 2017
2017-06-22 08:00:00 | Cyanotech Reports Financial Results for Fourth Quarter and Fiscal Year 2017
2017-03-20 12:02:57 | Cyanotech Corp. :CYAN-US: Earnings Analysis: Q3, 2017 By the Numbers : March 20, 2017
2017-02-16 16:20:19 | CYANOTECH CORP Files SEC form 8-K, Other Events
2017-02-07 16:40:19 | CYANOTECH CORP Files SEC form 10-Q, Quarterly Report
2016-12-19 06:05:38 | CYANOTECH CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
2016-11-11 20:00:08 | Kailua-Kona-based Cyanotech reports second-quarter financials
2016-11-11 11:51:44 | Cyanotech Corp. :CYAN-US: Earnings Analysis: Q2, 2017 By the Numbers : November 11, 2016
2016-11-10 09:00:49 | CYANOTECH CORP Files SEC form 10-Q, Quarterly Report
2016-10-25 17:05:07 | Cyanotech Names Nancy Katz as a Director
2016-10-25 16:30:00 | Cyanotech Names Nancy Katz as a Director